SLC40A1 and breast carcinoma: The effect of vamifeport and hepcidin on ferroportin degradation was evaluated, for the first time in vitro, in a human breast cancer cell line (T47D); expressing ferroportin, T47D cells were incubated with iron sulfate characterized by the stable isotope 58Fe [13].